Rubitecan
            目录号: A22040
    
            topoisomerase I 抑制剂
    
								
							Rubitecan(RFS 2000),一种Camptothecin衍生物,是一种口服活性的拓扑异构酶 I 抑制剂,具有广泛的抗肿瘤活性,并诱导蛋白质连接的DNA单链断裂,从而阻断分裂细胞中的DNA和RNA合成。
        | Discription | Rubitecan (RFS 2000), a Camptothecin derivative, is an orally active topoisomerase I inhibitor with broad antitumor activity, and induces protein-linked DNA single-strand breaks, thereby blocking DNA and RNA synthesis in dividing cells. | |||||
|---|---|---|---|---|---|---|
| Cell Research | 
                            
  | 
    
| 目录号 | A22040 | 
|---|---|
| 分子式 | C20H15N3O6 | 
| 分子量 | 393.35 | 
| CAS号 | 91421-42-0 | 
| SMILES | O=C1[C@](O)(CC)C2=C(CO1)C(N3CC4=CC5=C([N+]([O-])=O)C=CC=C5N=C4C3=C2)=O | 
| 其他名称 | RFS 2000, RFS2000, RFS-2000; 9-Nitrocamptothecin | 
| 储存条件 | Store lyophilized at -20ºC, keep desiccated.   | 
				
| In vitro | DMSO | 51 mg/mL (129.65 mM) | |
| Water | Insoluble | ||
| Ethanol | Insoluble | ||
| 
																	  *  <1 mg/ml means slightly soluble or insoluble. * Please note that Adooq tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations.  | 
																|||
| Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg | 
|---|---|---|---|
| 0.1 mM | 25.42 mL | 127.11 mL | 254.23 mL | 
| 0.5 mM | 5.08 mL | 25.42 mL | 50.85 mL | 
| 1 mM | 2.54 mL | 12.71 mL | 25.42 mL | 
| 5 mM | 0.51 mL | 2.54 mL | 5.08 mL | 
Calculate the dilution required to prepare a stock solution. This equation is commonly abbreviated as: C1V1 = C2V2